NC
NovaQuest Capital Management, L.L.C.
Concentrated strategyQuality / disciplined sizing
Total reported value
$54.3M
Reporting period: 2020-09-30 · Number of holdings: 2
NovaQuest Capital Management, L.L.C. disclosed 2 holdings in its latest 13F filing for the period ending 2020-09-30, with total reported value of $54.3M and a quarterly turnover rate of 45.6%.
Personality snowflake
- Concentration
- 100
- Portfolio Stability
- 45.58
- Momentum/Contrarian
- 50
- Sector conviction
- 0
- Diversification
- 4
- Sizing Uniformity
- 88.69
Recent moves
Add G637AM102
0.0% -$22.8M
Trim RVNCEUR
-63.9% -$9.2M
Holdings Map
New buyAddUnchangedTrim
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Myovant Sciences LTD | Stock-Other | 89.99% | +6.94% | — | |
| 2 | RVNCEUR | Revance Therapeutics INC | Stock-Other | 10.01% | -6.94% | -63.93% |
Reported value over time
Sector allocation
Not enough sector-mapped data yet
Sector allocation over time
Quarterly history
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2020-09-30 | 2 | $54.3M | 46 | 1G637AM2RVNCEUR |
| 2020-06-30 | 2 | $86.3M | 84 | 1G637AM2RVNCEUR |
| 2020-03-31 | 2 | $35.1M | 77 | 1G637AM2RVNCEUR |
| 2019-12-31 | 2 | $79.2M | 70 | 1G637AM2RVNCEUR |
| 2019-09-30 | 4 | $38.3M | 30 | 1RVNCEUR2G637AM |
| 2019-06-30 | 4 | $51.7M | 70 | 1G637AM2RVNCEUR |
| 2019-03-31 | 4 | $107.5M | 33 | 1G637AM2RVNCEUR |
| 2018-12-31 | 4 | $88.4M | 41 | 1G637AM2RVNCEUR |
| 2018-09-30 | 3 | $70.3M | 12 | 1RVNCEUR2G637AM |
| 2018-06-30 | 3 | $69.9M | 10 | 1RVNCEUR2G637AM |
| 2018-03-31 | 3 | $73.3M | 73 | 1RVNCEUR2G637AM |
| 2017-12-31 | 3 | $125.7M | 0 | 1RVNCEUR2G637AM |
Holding changes this quarter
NovaQuest Capital Management, L.L.C.'s most significant position changes for 2020-09-30: Trim: Revance Therapeutics INC (RVNCEUR) — shares -63.93%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Myovant Sciences LTD | +6.9% | — | Unchanged |
| 2 | RVNCEUR | Revance Therapeutics INC | -6.9% | -63.93% | Trim |
FAQ
What is NovaQuest Capital Management, L.L.C. and what type of investor is it?
NovaQuest Capital Management, L.L.C. is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2020-09-30), the firm manages a tracked equity portfolio valued at approximately $54.3M, spread across 2 disclosed positions.
What are NovaQuest Capital Management, L.L.C.'s largest equity positions?
Based on the latest 13F filing, NovaQuest Capital Management, L.L.C.'s top holdings by market value are:
1. Myovant Sciences LTD — $48.8M (90.0%)
2. Revance Therapeutics INC (RVNCEUR) — $5.4M (10.0%)
What changes did NovaQuest Capital Management, L.L.C. make in its most recent portfolio filing?
In the latest quarter, NovaQuest Capital Management, L.L.C. took a more defensive posture — trimming 1 positions and completely exiting 0 holdings. The largest of these moves: Trim: Revance Therapeutics INC (RVNCEUR) — shares -63.93%
What sectors does NovaQuest Capital Management, L.L.C. focus on?
Sector breakdown data is not yet available for NovaQuest Capital Management, L.L.C.. Check back after the next 13F processing cycle.